Free Trial

Nutex Health (NASDAQ:NUTX) Sees Unusually-High Trading Volume After Insider Buying Activity

Nutex Health logo with Medical background

Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) saw an uptick in trading volume on Monday after an insider bought additional shares in the company. 83,932 shares changed hands during mid-day trading, an increase of 54% from the previous session's volume of 54,518 shares.The stock last traded at $121.15 and had previously closed at $132.03.

Specifically, CFO Jon Christian Bates purchased 1,000 shares of Nutex Health stock in a transaction that occurred on Tuesday, April 8th. The shares were purchased at an average cost of $81.81 per share, with a total value of $81,810.00. Following the transaction, the chief financial officer now owns 4,888 shares of the company's stock, valued at approximately $399,887.28. The trade was a 25.72 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.

Wall Street Analyst Weigh In

Separately, Maxim Group lifted their price objective on shares of Nutex Health from $75.00 to $100.00 and gave the company a "buy" rating in a research note on Tuesday, April 8th.

Get Our Latest Analysis on Nutex Health

Nutex Health Trading Up 8.8 %

The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.74 and a current ratio of 1.77. The company has a market cap of $823.67 million, a P/E ratio of -15.87 and a beta of 0.27. The business has a fifty day simple moving average of $69.23 and a 200 day simple moving average of $45.04.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Monday, March 31st. The company reported $11.12 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $11.21. The firm had revenue of $81.30 million for the quarter, compared to analyst estimates of $81.13 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Bank of America Corp DE raised its stake in shares of Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after buying an additional 2,043 shares in the last quarter. Beaird Harris Wealth Management LLC acquired a new position in Nutex Health during the third quarter valued at $69,000. Northern Trust Corp acquired a new stake in shares of Nutex Health during the fourth quarter worth approximately $200,000. Baader Bank Aktiengesellschaft purchased a new position in shares of Nutex Health during the 4th quarter valued at $206,000. Finally, Millennium Management LLC purchased a new stake in shares of Nutex Health during the 4th quarter worth about $213,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Recommended Stories

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines